Southern SOMN Q1 2026 Earnings Why the Beat Matters AngloGold AU Q1 2026 Earnings Surprise EPS 251 Up Significant TrumpChina Talks Conclude Trade Oil and Taiwan Dominate Agenda Payoneer Global PAYO Q1 2026 Results Top Views on Strong Revenue Pfizer Wins Singapore Trademark Dispute with Merck Over Vaccine Brand Nationwide Faces Governance Concerns as Labour MP Raises Issues Before AGM Kevin Warsh Vows ReformOriented Approach as New Federal Reserve Chair US Jobless Claims Remain at Low Levels Signaling Labor Market Resilience AtHome Pediatric Care Devices Could Address Access Gap for Millions of Children Morrisons Plans to Close 100 Stores Amid Cost Pressures from Government Policies ASAN Q1 2026 Earnings EPS Beat Surprises Market Stock Surges 4 BioLineRx Ltd BLRX Q3 2024 Earnings Narrowed Losses and Pipeline Progress Amidst Low Revenue PCRX Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance CGBD Q1 2026 Earnings Earnings Slightly Miss Estimates as Stock Declines Insperity Q1 2026 Earnings EPS Beat Drives Strong Stock Reaction DSS Q3 2025 Earnings Cost Discipline Drives Significant EPS Beat Amid Revenue Uncertainty Leishen Energy Holding LSE Consolidates Near Resistance After Modest Gain Grupo Televisa TV Gains 108 as Shares Test MidRange Support Eaton Vance Municipal Income Trust EOT Edges Higher Modest Gains Amid Steady Income Focus Invesco Value Municipal Income Trust IIM Edges Higher Amid Steady Demand Bloomin Brands BLMN Rallies 42 as Restaurant Stock Tests Key Resistance TTI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Hexcel Corporation HXL Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction IHG Q4 2025 Earnings EPS Slightly Misses Estimates as Stock Edges Lower SGU Q1 2026 Earnings Strong Seasonal EPS Contributes to Solid Start Stock Slips BVN Q4 2025 Earnings Strong EPS Surprise Driven by Operational Gains Robert Kiyosaki Predicts Gold at 10000 and Silver at 200 Warns of Imminent Stock Market Crash EverQuote Q1 2026 Earnings EPS Surpasses Expectations by 1402 Stock Declines Amid Unclear Revenue Outlook GeneDx Holdings Warrants Rally 1477 From Penny Level Yet Resistance Remains Stubborn